Agios Appoints Rahul Ballal and Cynthia Smith to Board of
CAMBRIDGE, Mass., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism pioneering...
Source: globenewswire.com
Page 2 - Affymax News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Affymax. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Affymax Today - Breaking & Trending Today
Worldwide Genitourinary Partnering Industry 2022 Report - Featuring 3SBio, 4D Science, 180 Medical, A1M Pharma and Many More
/PRNewswire/ -- The "Global Genitourinary Partnering 2010-2022: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering....
Source: prnewswire.com
Critical Analysis: Affymax (OTCMKTS:AFFY) & Benitec Biopharma (NASDAQ:BNTC)
Benitec Biopharma (NASDAQ:BNTC – Get Rating) and Affymax (OTCMKTS:AFFY – Get Rating) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, valuation, dividends, analyst recommendations and risk. Institutional and Insider Ownership 20.2% of Benitec Biopharma shares are owned […]
Source: etfdailynews.com
Dr. Mike Holfinger Joins Alladapt as Chief Technical Officer
Alladapt Immunotherapeutics Inc., a private, clinical-stage biopharmaceutical company focused on the development of prescription therapeutics to address
Source: einnews.com
T-knife Announces Appointment of Thomas M. Soloway as Chief Executive Officer and Camille A. ...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. T-knife Announces Appointment of Thomas M. Soloway as Chief Executive Officer and Camille A. ... AKAMPIONJanuary 19, 2021 GMT San Francisco, CA / Berlin, Germany – January 19, 2021 — T-knife GmbH, a next-generation adoptive T-cell therapy company leveraging its proprietary humanized T-cell receptor (HuTCR) mouse platform to treat solid tumors, today announced the appointment of Thomas M. Soloway as Chief Executive Officer and Camille A. Landis as Chief Business Officer & Chief Financial Officer....
Source: apnews.com